Advertisement
Skip to Content

Lescarden Inc LCAR Stock Quote

| Rating as of

PINX: LCAR

Last close prices updated as of Dec 13, 2022, 12:19 PM EST | USD
  • Last Close 0
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style
  • Day Range < 0.01  –  < 0.01
  • Year Range < 0.01  –  < 0.01
  • Market Cap 63.6223
  • Volume / Avg 4,000.0 /  4,000.0
  • Price / Sales 0.75
  • Price / Book
  • Forward Div Yield 1.43%
  • Trailing Div Yield

Morningstar‘s Stock Analysis LCAR

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics LCAR

Company Profile LCAR

Business Description

Lescarden Inc is a biotechnology company. It is engaged in the research, testing, and development of medications for the control and cure of various diseases and the licensing of its technologies for commercialization by other companies. Its lead product is Catrix Wound Dressing for the management of chronic lesions and burns, as well as for non-healing wounds, including decubitus ulcers, venous stasis ulcers, and diabetic ulcers. In addition, the group is also involved in the line of Catrix-based skin care products targeting the plastic surgery, dermatology and medical spa markets. Geographically, the business presence of the firm is seen in the regions of United States, Europe, and South Korea.

Contact
420 Lexington Avenue, Suite 212
New York, NY, 10170
Industry Biotechnology
Employees 1

FAQs for Lescarden Inc Stock

Yes. LCAR has a forward dividend yield of 1.43%. See LCAR’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

LCAR’s market cap is 63.62.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

LCAR’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare LCAR’s historical performance against its industry peers and the overall market.